Androgen receptor gene expression in leucocytes is hormonally regulated: implications for gender differences in disease pathogenesis
- 22 December 2004
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 62 (1) , 56-63
Abstract
Summary: Objective There is evidence that male sex hormones influence the rate of progression of inflammatory and cardiovascular diseases. We have previously shown that human leucocytes and arterial cells isolated from male donors express more androgen receptor (AR) than those from female cells, with potentially pro‐atherogenic effects. We now investigate whether the gender difference in AR expression is due to genetic or hormonal regulation.Design and Patients The influence of hormones on AR expression were studied in hpg mice (a mouse model of androgen deficiency) treated with testosterone, oestradiol or dihydrotestosterone (DHT). Blood samples were obtained for leucocyte AR expression and hormone levels from 53 subjects, grouped into: 12 male [six young adult (27–45 years), six elderly (71–79 years)] and six female (young adult 25–45 years) healthy controls; six male‐to‐female transsexuals (M2F; 20–50 years) receiving stable pharmacological oral oestrogen treatment; six female‐to‐male transsexuals (F2M; 31–51 years) receiving stable androgen replacement therapy; five younger men (18–56 years) who had been receiving long‐term androgen replacement therapy for hypogonadal disease; six elderly men (72–88 years) who had undergone medical castration for prostate cancer treatment; and 12 male bone marrow transplant recipients (BMT; 23–65 years) from either male or female donors.Measurements Serum testosterone and oestradiol concentrations were measured by established immunoflurometric assays from unextracted human serum. AR mRNA levels were measured by RT–PCR and AR protein levels by western blot (cell culture) or immunohistochemistry (mouse arteries).Results We found that AR mRNA levels were significantly down‐regulated in the leucocytes of hpg mice that were treated with exogenous testosterone, oestradiol or DHT. AR protein levels were also lower in aortic tissue from the same mice. In humans, we found AR expression was significantly down‐regulated by exogenous treatment with testosterone in F2M (31 ± 13%, compared with control) or oestradiol in M2F (22 ± 5%) but was significantly up‐regulated by endogenous testosterone in BMT (128 ± 17%). Low androgen levels measured in castrated older men were associated with markedly increased AR expression (207 ± 26%, P < 0·05) compared with age‐matched older male controls (100 ± 2%).Conclusions Our results indicate a regulated ability of vascular cells to respond to sex hormones, with the effects of exogenous therapies differing markedly from those due to endogenous sex hormones. We conclude that the gender difference in AR expression in vascular cells is hormonally, rather than genetically, controlled.Keywords
This publication has 28 references indexed in Scilit:
- The androgen receptor mRNABioEssays, 2004
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Intracellular signaling pathways: nongenomic actions of estrogens and ligand-independent activation of estrogen receptorsFrontiers in Bioscience-Landmark, 2001
- Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assaysJournal of Molecular Endocrinology, 2000
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Programming of Growth Hormone Secretion and Bone Mineral Density in Elderly Men: A HypothesisThe Journal of Clinical Endocrinology & Metabolism, 1998
- Induction of spermatogenesis by androgens in gonadotropin-deficient (hpg) miceEndocrinology, 1995
- Estrogen and Progesterone Receptors in Endometrial CarcinomaInternational Journal of Gynecological Pathology, 1993
- Testicular blood flow and vasomotion can be maintained by testosterone in Leydig cell‐depleted ratsInternational Journal of Andrology, 1992
- Sex hormones and coronary disease: a review of the clinical studiesSteroids, 1990